Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 03, 2025

Get In Touch

Strict Glucose Control Without Hypoglycemia Prevents Retinopathy: JAMA Diabetes and Endocrinology

Strict Glucose Control Without Hypoglycemia Prevents Retinopathy: JAMA

  • 01 November 2025
  • 1 day ago

Dapagliflozin and Sitagliptin FDC: Exploring Early Initiation Benefits In Young Newly Diagnosed T2D in India Diabetes and Endocrinology

Dapagliflozin and Sitagliptin FDC: Exploring Early Initiation Benefits In Young Newly Diagnosed T2D in India

  • 01 November 2025
  • 1 day ago

SGLT2 Inhibitors Linked to Lower Risk of Kidney Stones in Patients With Type 2 Diabetes: Study Shows Diabetes and Endocrinology

SGLT2 Inhibitors Linked to Lower Risk of Kidney Stones in Patients With Type 2 Diabetes: Study Shows

  • 30 October 2025
  • 3 days ago

Type 2 Diabetes Develops Earlier and More Severely in Congenital Heart Disease Patients: Study Shows Diabetes and Endocrinology

Type 2 Diabetes Develops Earlier and More Severely in Congenital Heart Disease Patients: Study Shows

  • 30 October 2025
  • 3 days ago

Automated Insulin Delivery Benefits Adults with Type 2 Diabetes Regardless of C-Peptide Levels: Study Finds Diabetes and Endocrinology

Automated Insulin Delivery Benefits Adults with Type 2 Diabetes Regardless of C-Peptide Levels: Study Finds

  • 27 October 2025
  • 6 days ago

Sun Pharma Gets CDSCO Panel Approval to Conduct Phase III Study of Oral Semaglutide Pharma News

Sun Pharma Gets CDSCO Panel Approval to Conduct Phase III Study of Oral Semaglutide

  • 25 October 2025
  • 1 week ago

GLP-1 Agonists Linked to Increased Nutritional Deficiencies, Reveals Research Diabetes and Endocrinology

GLP-1 Agonists Linked to Increased Nutritional Deficiencies, Reveals Research

  • 25 October 2025
  • 1 week ago

Is Low-Carbohydrate Diet Safe and Effective for Type 2 Diabetes Remission in Long-Term? Diabetes and Endocrinology

Is Low-Carbohydrate Diet Safe and Effective for Type 2 Diabetes Remission in Long-Term?

  • 24 October 2025
  • 1 week ago

FDA Approves Oral Semaglutide for Cardiovascular Risk Reduction in Type 2 Diabetes Diabetes and Endocrinology

FDA Approves Oral Semaglutide for Cardiovascular Risk Reduction in Type 2 Diabetes

  • 23 October 2025
  • 1 week ago

Mediterranean Diet and Lifestyle Changes Cut Type 2 Diabetes Risk by 31 Percent: Study Finds Diabetes and Endocrinology

Mediterranean Diet and Lifestyle Changes Cut Type 2 Diabetes Risk by 31 Percent: Study Finds

  • 18 October 2025
  • 2 weeks ago

Recent News

Himachal notifies Resident doctor policy 2025

  • 02 November, 2025

Pfizer files lawsuit against Metsera, its Director...

  • 02 November, 2025

Health Ministry achieves 3 Guinness World Records...

  • 02 November, 2025

Roche gets CE mark for Elecsys Dengue Ag test to d...

  • 02 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.